In a mouse model of abdominal aortic aneurysm (AAA), genetic knockout (Pcsk9−/−) or pharmacological inhibition (PCSK9‐targeting antibodies/siRNA) significantly attenuated vascular inflammation and structural degeneration. The gene discussed is PCSK9; the disease is triple-A syndrome.